A detailed history of Monaco Asset Management Sam transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Monaco Asset Management Sam holds 100,000 shares of ROIV stock, worth $1.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
100,000
Previous 40,000 150.0%
Holding current value
$1.2 Million
Previous $422,000 173.46%
% of portfolio
0.17%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$10.17 - $12.5 $610,200 - $750,000
60,000 Added 150.0%
100,000 $1.15 Million
Q2 2024

Aug 07, 2024

BUY
$10.36 - $11.74 $414,400 - $469,600
40,000 New
40,000 $422,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.43B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Monaco Asset Management Sam Portfolio

Follow Monaco Asset Management Sam and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monaco Asset Management Sam, based on Form 13F filings with the SEC.

News

Stay updated on Monaco Asset Management Sam with notifications on news.